| Meatable | |
| Type: | Privately held company |
| Industry: | Food technology |
| Founded: | 2018 |
| Founders: | Krijn de Nood, Daan Luining, Mark Kotter |
| Location City: | Delft |
| Location Country: | Netherlands |
Meatable is a Dutch biotechnology company aimed at cultured meat, particularly pork.
Meatable was co-founded by Krijn de Nood, Daan Luining, and Mark Kotter in 2018.[1] It began operating on the campus of Delft University of Technology.[2] and by 2018 reported it had succeeded growing meat using pluripotent stem cells from animal umbilical cords.[3] becoming one of the first start-ups to eliminate fetal bovine serum.[4] On 26 September 2018, Luining represented Meatable at a round table discussion on cultured meat in the Dutch House of Representatives.[5] In early October 2018, Meatable attracted 3.5 million euros in funding from investors.[6]
Meatable presented at the Consumer Electronics Show (CES) in Las Vegas in January 2020,[2] stating that it sought to present proof of concept by the end of the year.[7] By then, Meatable was working with scientists from Cambridge and Stanford to produce a hamburger within three weeks from a single stem cell via a process the company had patented.[2]
In 2021, Meatable obtained funding from various investors worth 40 million euros (47 million US dollars).[8] Its total capital at the time was approximately 53 million euros (60 million US dollars).[1] By April 2021, the staff of Meatable had grown to over 40 people with 15 different nationalities, representing many different fields and coming from many universities.[1] The same year, Meatable announced that it had entered into an agreement with DSM in order to 'make cultured meat affordable and accessible on a large scale.'[9]
In April 2024, Meatable was the first company in the European Union to receive regulatory approval from the EFSA for a public tasting of cultured meat, in this case sausage, amid much international and national media attention.[10] [11] [12]